+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cystic Fibrosis Therapeutics: Global Strategic Business Report

  • PDF Icon

    Report

  • 282 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 1244803

Global Cystic Fibrosis Therapeutics Market to Reach $46.8 Billion by 2030

The global market for Cystic Fibrosis Therapeutics estimated at US$15.4 Billion in the year 2022, is projected to reach a revised size of US$46.8 Billion by 2030, growing at a CAGR of 14.9% over the analysis period 2022-2030. Medication, one of the segments analyzed in the report, is projected to record 15.3% CAGR and reach US$42.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Devices segment is readjusted to a revised 12.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.2 Billion, While China is Forecast to Grow at 21.2% CAGR

The Cystic Fibrosis Therapeutics market in the U.S. is estimated at US$4.2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$12.1 Billion by the year 2030 trailing a CAGR of 21.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.5% and 12.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.2% CAGR.

Select Competitors (Total 56 Featured) -

  • AbbVie Inc.
  • Galapagos NV
  • Genentech
  • Gilead Sciences Inc.
  • Novartis AG
  • Vertex Pharmaceuticals Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Frequently Asked Questions about the Global Market for Cystic Fibrosis Therapeutics

What is the estimated value of the Global Market for Cystic Fibrosis Therapeutics?

The Global Market for Cystic Fibrosis Therapeutics was estimated to be valued at $11.2 Billion in 2020.

What is the growth rate of the Global Market for Cystic Fibrosis Therapeutics?

The growth rate of the Global Market for Cystic Fibrosis Therapeutics is 14.9%, with an estimated value of $29.6 Billion by 2027.

What is the forecasted size of the Global Market for Cystic Fibrosis Therapeutics?

The Global Market for Cystic Fibrosis Therapeutics is estimated to be worth $29.6 Billion by 2027.

Who are the key companies in the Global Market for Cystic Fibrosis Therapeutics?

Key companies in the Global Market for Cystic Fibrosis Therapeutics include AbbVie Inc., Galapagos NV, Genentech, Gilead Sciences Inc., Novartis AG and Vertex Pharmaceuticals Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Cystic Fibrosis - A Prelude
  • Recent Market Activity
  • CF Disease Prevalence: A Brief Note
  • Treatment Modalities for Cystic Fibrosis
  • CFTR Modulators: Key Drug Category
  • Competitive Scenario
  • Vertex: At the Forefront of Cystic Fibrosis Therapeutics
  • Cystic Fibrosis \Therapeutics - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
  • AbbVie Inc. (USA)
  • Galapagos NV (Belgium)
  • Genentech, Inc. (USA)
  • Gilead Sciences, Inc. (USA)
  • Novartis AG (Switzerland)
  • Vertex Pharmaceuticals (USA)
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Cystic Fibrosis Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Cystic Fibrosis Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Medication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Other Treatment Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Other Treatment Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Other Treatment Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 18: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 21: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 22: World Cystic Fibrosis Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 24: USA Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 25: USA 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2023 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 27: USA Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 28: USA 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2023 & 2030
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 31: Canada 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2023 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 33: Canada Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 34: Canada 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2023 & 2030
JAPAN
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 37: Japan 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2023 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: Japan Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 40: Japan 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2023 & 2030
CHINA
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 42: China Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 43: China 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2023 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: China Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 46: China 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2023 & 2030
EUROPE
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Cystic Fibrosis Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 49: Europe 16-Year Perspective for Cystic Fibrosis Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 52: Europe 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2023 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 55: Europe 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2023 & 2030
FRANCE
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 57: France Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 58: France 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2023 & 2030
  • Table 59: France Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 60: France Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 61: France 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2023 & 2030
GERMANY
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 64: Germany 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2023 & 2030
  • Table 65: Germany Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 66: Germany Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 67: Germany 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2023 & 2030
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 70: Italy 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2023 & 2030
  • Table 71: Italy Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 72: Italy Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 73: Italy 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2023 & 2030
UNITED KINGDOM
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 75: UK Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 76: UK 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2023 & 2030
  • Table 77: UK Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 78: UK Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 79: UK 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2023 & 2030
SPAIN
  • Table 80: Spain Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 81: Spain Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 82: Spain 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2023 & 2030
  • Table 83: Spain Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 84: Spain Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 85: Spain 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2023 & 2030
RUSSIA
  • Table 86: Russia Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 87: Russia Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 88: Russia 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2023 & 2030
  • Table 89: Russia Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 90: Russia Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 91: Russia 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2023 & 2030
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 94: Rest of Europe 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2023 & 2030
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 96: Rest of Europe Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 97: Rest of Europe 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2023 & 2030
ASIA-PACIFIC
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Cystic Fibrosis Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 100: Asia-Pacific 16-Year Perspective for Cystic Fibrosis Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 103: Asia-Pacific 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2023 & 2030
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 106: Asia-Pacific 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2023 & 2030
AUSTRALIA
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AbbVie Inc.
  • Galapagos NV
  • Genentech
  • Gilead Sciences Inc.
  • Novartis AG
  • Vertex Pharmaceuticals Inc.